David Kirn

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Scott Bizily as Attorney-in-Fact for David Kirn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Kirn:

Company Role Class Num Shares Value Price $ Report Date Ownership
4D Molecular Therapeutics, Inc. Chief Executive Officer, Director Common Stock 1,059,153 $23,817,068 $22.49 10 Jul 2024 Direct
4D Molecular Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 267,500 06 Mar 2025 Direct

Insider Reports Filed by David Kirn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FDMT 4D Molecular Therapeutics, Inc. 06 Mar 2025 1 $0 4 Chief Executive Officer, Director 10 Mar 2025, 19:58
FDMT 4D Molecular Therapeutics, Inc. 10 Jul 2024 5 -$102,521 4 Chief Executive Officer, Director 12 Jul 2024, 17:46
FDMT 4D Molecular Therapeutics, Inc. 24 Jun 2024 3 -$112,261 4 Chief Executive Officer, Director 26 Jun 2024, 17:07
FDMT 4D Molecular Therapeutics, Inc. 08 Feb 2024 1 -$2,495,822 4 Chief Executive Officer, Director 12 Feb 2024, 20:22
FDMT 4D Molecular Therapeutics, Inc. 23 Jan 2024 1 -$104,851 4 Chief Executive Officer, Director 25 Jan 2024, 16:59
FDMT 4D Molecular Therapeutics, Inc. 15 Dec 2023 5 -$1,959,354 4 Chief Executive Officer, Director 08 Jan 2024, 16:19
FDMT 4D Molecular Therapeutics, Inc. 11 Dec 2023 1 $0 4 Chief Executive Officer, Director 13 Dec 2023, 16:05
FDMT 4D Molecular Therapeutics, Inc. 02 May 2023 2 $0 4 Chief Executive Officer, Director 04 May 2023, 20:09
FDMT 4D Molecular Therapeutics, Inc. 21 Feb 2023 3 -$709,873 4 Chief Executive Officer, Director 23 Feb 2023, 18:56
FDMT 4D Molecular Therapeutics, Inc. 10 Feb 2023 1 $0 4 Chief Executive Officer, Director 14 Feb 2023, 19:24
FDMT 4D Molecular Therapeutics, Inc. 19 Jan 2023 2 -$392,474 4 Chief Executive Officer, Director 23 Jan 2023, 18:57
FDMT 4D Molecular Therapeutics, Inc. 15 Dec 2022 4 -$2,018,344 4 Chief Executive Officer, Director, 10%+ Owner 19 Dec 2022, 16:56
FDMT 4D Molecular Therapeutics Inc. 01 Feb 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 03 Feb 2022, 16:40